DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. - sprookjes - yvandenbroek - TriplyDB

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

http://www.wikidata.org/entity/Q37584540

about

Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.Oxidative stress and cellular pathologies in Parkinson's disease.Alpha-synuclein oligomers: a new hope.Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo.N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein.13 reasons why the brain is susceptible to oxidative stress.Membrane cholesterol mediates the cellular effects of monolayer graphene substrates.Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.

P2860

Q39294770-7D063F22-EA4A-4B11-B42B-AB8056C22045 Q46252606-77C8E882-77FE-4F94-AB57-E00433DBB7BB Q46321755-D9084C39-440F-4E6B-9E2B-17B6B6621D00 Q47549125-3BD30CAF-61F5-4C81-B3F1-AE23F3F0BE37 Q48176779-4CA9D3CD-35C7-4634-932E-93CD84E91B13 Q49374861-2351670E-1082-4E52-92EB-5D4250CAC21E Q50136704-3773F33B-EA47-4A76-8BF3-26E104540F77 Q50330744-13CFA520-6A96-4C59-B82C-98E81C3E2FCE Q52373049-B2B2AC4E-576E-4719-9838-D1319CFF24A9 Q55361950-AF262B19-4993-4AFB-A393-369D08565FE2

P2860

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

http://www.wikidata.org/entity/Q37584540

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@en

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@nl

type

label

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@en

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@nl

prefLabel

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@en

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

@nl

P1433

Q37584540-4E1BF236-9C8A-4AB8-8DB2-5E6898210F69

P1476

Q37584540-46B99531-A804-40F1-A841-8C2D6AFFF1FA

P2093

Q37584540-04B3D5D2-81B4-48E2-BC1D-15713A10FDF9

Q37584540-07B9C9F0-042D-4DE4-8937-CF52A661785D

Q37584540-316A8255-676E-412C-B9CA-3E89736B0C69

Q37584540-5C3160CB-8453-444D-93D1-836A889DDFBE

Q37584540-CE2555F6-C368-49D1-B546-C077E9FA5E0B

Q37584540-D92E82A8-C10E-48F2-90E0-BB60876D8908

Q37584540-E0BD8CC4-4A58-4606-A7CA-7D0D31DE917F

Q37584540-E97FEA34-137F-4B02-AFB9-6C484E8BA357

P2860

Q37584540-08006E53-3125-4D5B-95EE-48582A226150

Q37584540-09F66C76-1D83-43DD-9345-DD5F3D32AEDF

Q37584540-194B74B2-9A89-4AD3-B955-D9559D47852C

Q37584540-1AB29264-9F40-404A-B241-7B4ECEA27A77

Q37584540-1B5C7E70-B145-4775-B502-52DE32BF3867

Q37584540-1BE75875-3192-435C-BDD1-F69AB9B73DE3

Q37584540-1D58C0B5-FE6B-4D22-8093-6DC6A45AB942

Q37584540-21D5AF55-72E9-4DF0-9811-D78B83ABCA8C

Q37584540-22C97E3C-83E2-4CF8-897F-1950C91D7A06

Q37584540-2774B9E1-E116-41BE-92B7-8D3548A28F6B

P2888

Q37584540-005394A8-DE0D-4191-91E5-606EFE985092

P304

Q37584540-25CEAA8E-4431-4CAF-BD28-5C0E0D396E5E

P31

Q37584540-739C8D7D-AC6F-42F1-9A90-4B5A548FF234

P356

Q37584540-56C3E1F1-0AA5-43B2-8202-330D033F1B3D

P407

Q37584540-6E04450B-77C8-4344-ABF6-579905EC005A

P478

Q37584540-D6FABA15-F9E6-4970-9186-68B4DE97E3FA

P50

Q37584540-7AA181BD-9EA2-4BFD-B11A-1F81A91296CB

Q37584540-A341F16E-7AA6-40CA-A8F2-1E1CCC15F420

Q37584540-BBF4ECD5-F0EA-47B9-A42F-75CB16AF8DB0

Q37584540-BF07E9E6-5330-4BA5-935B-E93E39EA30A1

Q37584540-C41BA1D1-5A17-489B-AC20-4FC934EB084D

Q37584540-E502B851-52DA-4DED-BA08-76E26027F36D

P577

Q37584540-26FA547D-8868-419B-9F08-2996D0756BBC

P698

Q37584540-311F98EE-9013-4209-BA74-91C1E25683E8

P921

Q37584540-684ABBC3-CBE9-4816-B7F2-FF7DAF39A04F

P932

Q37584540-2EA194E7-A7B5-44BF-A2FC-2E977CEF9CE9

P356

P1433

Scientific Reports

P1476

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function

@en

P2093

E Greggio

http://www.w3.org/2001/XMLSchema#string

G Berti

http://www.w3.org/2001/XMLSchema#string

I Tessari

http://www.w3.org/2001/XMLSchema#string

L Casella

http://www.w3.org/2001/XMLSchema#string

L Lunelli

http://www.w3.org/2001/XMLSchema#string

M Bisaglia

http://www.w3.org/2001/XMLSchema#string

M Zanetti

http://www.w3.org/2001/XMLSchema#string

S Girotto

http://www.w3.org/2001/XMLSchema#string

P2860

LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool

The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity

Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons

Protein degradation pathways in Parkinson's disease: curse or blessing

Alpha-synuclein in Lewy bodies

Molecular anatomy of a trafficking organelle

P2888

P304

40699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP40699

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mauro Dalla Serra

Emanuele Ferrari

Nicoletta Plotegher

Marina Veronesi

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28084443

http://www.w3.org/2001/XMLSchema#string

P921

P932

5233976

http://www.w3.org/2001/XMLSchema#string